PharmaCorp RX Appoints Andrew Hodson as New CFO
PharmaCorp RX has announced the appointment of Andrew Hodson as its new chief financial officer, effective October 27, 2026. This follows Terri Tatchell's decision to retire from her role as CFO on the same date. Tatchell will remain with the company for an additional three months in a consulting capacity before fully retiring. The leadership change is expected to provide continuity and strategic direction during this transition period, though no immediate financial impact has been disclosed at this time.
Topics: CFO Appointment Leadership Transition